Healthcare Sector Stocks
The Healthcare sector has a total of 1066 stocks, with a combined market cap of $8.32 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.39.
Market Cap
8.32T
Revenue
4.52T
Profits
201.12B
PE Ratio
41.39
Profit Margin
4.45%
Dividend Yield
0.42%
1067 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 824.56B | 2.04% | 2,622,175 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 544.59B | -0.03% | 9,003,102 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 354.64B | -2.25% | 7,645,613 | 61.16B |
| 4 | UNH | UnitedHealth Group Incorporated | 321.07B | 2.17% | 11,806,796 | 447.57B |
| 5 | AZN | AstraZeneca PLC | 304.55B | -0.50% | 1,578,630 | 58.74B |
| 6 | NVS | Novartis AG | 281.78B | -0.44% | 1,026,307 | 56.67B |
| 7 | MRK | Merck & Co., Inc. | 278.82B | 0.29% | 8,036,633 | 65.01B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 191.01B | -2.02% | 1,801,375 | 44.56B |
| 9 | AMGN | Amgen Inc. | 186.69B | 0.31% | 2,136,427 | 36.75B |
| 10 | NVO | Novo Nordisk A/S | 173.29B | -0.68% | 17,619,323 | 48.59B |
| 11 | ISRG | Intuitive Surgical, Inc. | 171.77B | 7.16% | 4,437,785 | 10.58B |
| 12 | GILD | Gilead Sciences, Inc. | 164.96B | -0.29% | 6,695,511 | 29.44B |
| 13 | ABT | Abbott Laboratories | 159.71B | -1.10% | 11,983,444 | 45.13B |
| 14 | PFE | Pfizer Inc. | 152.45B | -1.87% | 35,244,070 | 62.58B |
| 15 | DHR | Danaher Corporation | 130.26B | -5.40% | 5,899,703 | 24.78B |
| 16 | SYK | Stryker Corporation | 126.14B | 0.63% | 2,328,481 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.05B | -0.99% | 7,500,035 | 48.19B |
| 18 | SNY | Sanofi | 114.32B | -0.49% | 2,857,448 | 54.85B |
| 19 | GSK | GSK plc | 111.95B | -0.75% | 3,584,505 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 111.33B | 0.25% | 734,334 | 12.00B |
| 21 | MDT | Medtronic plc | 106.84B | 1.49% | 10,669,179 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 105.38B | 0.03% | 973,267 | 75.60B |
| 23 | MCK | McKesson Corporation | 101.57B | -1.55% | 1,117,977 | 397.96B |
| 24 | CVS | CVS Health Corporation | 97.95B | -1.20% | 5,147,183 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 96.41B | 8.99% | 40,404,559 | 20.61B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.61B | -0.10% | 901,856 | 14.34B |
| 27 | CI | The Cigna Group | 72.43B | -0.72% | 1,357,878 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 71.27B | 0.03% | 2,997,312 | 200.42B |
| 29 | MDLN | Medline Inc. | 61.95B | -0.74% | 3,507,979 | 28.43B |
| 30 | COR | Cencora, Inc. | 59.97B | -1.31% | 2,215,533 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 52.71B | -2.70% | 3,133,412 | 28.48B |
| 32 | ARGX | argenx SE | 49.44B | -1.51% | 380,820 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 49.42B | -0.56% | 3,514,667 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 47.19B | -2.13% | 2,518,037 | 244.67B |
| 35 | EW | Edwards Lifesciences Corporation | 47.01B | 2.28% | 4,943,287 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.94B | 1.64% | 364,628 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.32B | -0.66% | 2,690,726 | 21.92B |
| 38 | HLN | Haleon plc | 41.62B | -1.78% | 6,458,527 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.19B | 0.70% | 1,003,652 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.62B | -1.79% | 1,275,299 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.35B | -0.22% | 3,511,531 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.65B | 0.03% | 183,124 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 34.05B | -1.33% | 1,800,366 | 7.07B |
| 44 | WAT | Waters Corporation | 32.82B | -0.25% | 719,486 | 3.17B |
| 45 | GEHC | GE HealthCare Technologies Inc. | 32.57B | -1.22% | 3,558,094 | 20.63B |
| 46 | RMD | ResMed Inc. | 32.20B | 0.37% | 833,901 | 5.40B |
| 47 | INSM | Insmed Incorporated | 31.19B | 2.48% | 1,819,999 | 606.42M |
| 48 | RVMD | Revolution Medicines, Inc. | 29.76B | -4.97% | 3,731,761 | - |
| 49 | RPRX | Royalty Pharma plc | 29.47B | 0.49% | 2,617,984 | 2.38B |
| 50 | NTRA | Natera, Inc. | 29.45B | 1.15% | 1,001,388 | 2.31B |
| 51 | IQV | IQVIA Holdings Inc. | 29.41B | -0.27% | 1,284,345 | 16.31B |
| 52 | BIIB | Biogen Inc. | 27.89B | 2.22% | 1,327,860 | 9.89B |
| 53 | BNTX | BioNTech SE | 27.46B | -2.69% | 1,214,165 | 3.37B |
| 54 | PHG | Koninklijke Philips N.V. | 26.98B | -0.84% | 914,868 | 20.94B |
| 55 | VEEV | Veeva Systems Inc. | 26.75B | -2.39% | 2,120,269 | 3.20B |
| 56 | MTD | Mettler-Toledo International Inc. | 26.53B | -1.07% | 92,926 | 4.03B |
| 57 | HUM | Humana Inc. | 26.10B | 0.02% | 1,873,627 | 129.66B |
| 58 | UTHR | United Therapeutics Corporation | 25.17B | 0.14% | 514,668 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 24.47B | 1.29% | 2,691,991 | 4.66B |
| 60 | DGX | Quest Diagnostics Incorporated | 22.58B | -0.51% | 1,609,402 | 11.28B |
| 61 | LH | Labcorp Holdings Inc. | 22.41B | -0.29% | 626,175 | 13.95B |
| 62 | MRNA | Moderna, Inc. | 22.05B | 2.53% | 3,506,516 | 1.94B |
| 63 | STE | STERIS plc | 21.92B | 1.87% | 848,636 | 5.83B |
| 64 | ROIV | Roivant Sciences Ltd. | 20.86B | -0.48% | 8,451,801 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 19.82B | -1.12% | 1,154,616 | 4.34B |
| 66 | WST | West Pharmaceutical Services, Inc. | 19.78B | -0.11% | 1,007,042 | 3.07B |
| 67 | INCY | Incyte Corporation | 19.25B | 0.54% | 1,012,603 | 5.14B |
| 68 | CNC | Centene Corporation | 19.14B | -0.54% | 4,507,512 | 176.15B |
| 69 | SMMT | Summit Therapeutics Inc. | 19.06B | -6.82% | 8,248,900 | - |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 18.01B | 0.38% | 1,527,209 | 8.23B |
| 71 | GMAB | Genmab A/S | 17.10B | 2.33% | 1,861,406 | 3.72B |
| 72 | VTRS | Viatris Inc. | 16.91B | -1.43% | 8,880,930 | 14.30B |
| 73 | THC | Tenet Healthcare Corporation | 16.75B | 3.10% | 1,253,240 | 21.31B |
| 74 | MEDP | Medpace Holdings, Inc. | 14.52B | -1.25% | 444,510 | 2.53B |
| 75 | RGC | Regencell Bioscience Holdings Limited | 14.48B | 3.13% | 139,451 | - |
| 76 | BBIO | BridgeBio Pharma, Inc. | 14.43B | -2.28% | 1,484,486 | 502.08M |
| 77 | ASND | Ascendis Pharma A/S | 14.27B | -3.85% | 1,809,578 | 845.52M |
| 78 | ALGN | Align Technology, Inc. | 14.04B | 0.44% | 922,512 | 4.03B |
| 79 | SNN | Smith & Nephew plc | 14.01B | -0.30% | 1,260,259 | 6.16B |
| 80 | PODD | Insulet Corporation | 13.41B | 0.67% | 764,107 | 2.71B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.19B | 0.74% | 753,438 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 13.06B | 1.59% | 1,148,331 | 1.40B |
| 83 | COO | The Cooper Companies, Inc. | 13.06B | -0.56% | 2,223,382 | 4.15B |
| 84 | GMED | Globus Medical, Inc. | 12.85B | 1.25% | 754,306 | 2.94B |
| 85 | JAZZ | Jazz Pharmaceuticals plc | 12.46B | 1.69% | 1,053,284 | 4.27B |
| 86 | FMS | Fresenius Medical Care AG | 12.39B | -0.39% | 612,521 | 23.05B |
| 87 | IONS | Ionis Pharmaceuticals, Inc. | 12.36B | 0.07% | 2,024,003 | 943.71M |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.14B | 0.27% | 199,173 | 958.40M |
| 89 | SOLV | Solventum Corporation | 11.98B | 0.20% | 629,062 | 8.33B |
| 90 | EXEL | Exelixis, Inc. | 11.90B | 2.09% | 3,533,576 | 2.32B |
| 91 | GH | Guardant Health, Inc. | 11.75B | -0.89% | 1,895,438 | 982.02M |
| 92 | ELAN | Elanco Animal Health Incorporated | 11.22B | -0.66% | 4,921,592 | 4.72B |
| 93 | UHS | Universal Health Services, Inc. | 11.03B | 1.22% | 450,856 | 17.36B |
| 94 | ENSG | The Ensign Group, Inc. | 10.88B | -2.88% | 589,110 | 5.06B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.80B | 0.55% | 2,912,629 | 3.85B |
| 96 | RVTY | Revvity, Inc. | 10.54B | 0.01% | 1,097,558 | 2.86B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -0.86% | 1,283,471 | 3.22B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.35B | 4.04% | 2,190,060 | 1.09B |
| 99 | EHC | Encompass Health Corporation | 10.16B | -0.58% | 873,635 | 5.94B |
| 100 | DVA | DaVita Inc. | 10.05B | 1.68% | 540,259 | 13.64B |
| 101 | TEM | Tempus AI, Inc. | 9.95B | 0.65% | 3,852,894 | 1.27B |
| 102 | BTSG | BrightSpring Health Services, Inc. | 9.67B | 2.32% | 1,357,169 | 12.91B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 9.54B | 1.89% | 614,458 | 638.50M |
| 104 | BAX | Baxter International Inc. | 9.45B | -0.97% | 4,560,622 | 11.24B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.39B | -1.04% | 203,656 | 7.46M |
| 106 | MASI | Masimo Corporation | 9.32B | 0.06% | 606,229 | 1.53B |
| 107 | ABVX | ABIVAX Société Anonyme | 9.20B | 4.09% | 656,797 | 5.37M |
| 108 | TECH | Bio-Techne Corporation | 9.17B | -1.83% | 1,132,715 | 1.22B |
| 109 | CRL | Charles River Laboratories International, Inc. | 9.12B | 0.93% | 865,936 | 4.02B |
| 110 | HSIC | Henry Schein, Inc. | 8.96B | -0.93% | 1,031,070 | 13.18B |
| 111 | ICLR | ICON Public Limited Company | 8.81B | 0.22% | 1,164,354 | 8.10B |
| 112 | PCVX | Vaxcyte, Inc. | 8.75B | 0.43% | 817,213 | - |
| 113 | NUVL | Nuvalent, Inc. | 8.56B | 1.61% | 581,475 | - |
| 114 | IBRX | ImmunityBio, Inc. | 8.33B | -0.37% | 11,414,438 | 113.29M |
| 115 | QGEN | Qiagen N.V. | 8.27B | -0.32% | 1,378,151 | 2.09B |
| 116 | CYTK | Cytokinetics, Incorporated | 8.23B | 0.68% | 1,181,379 | 88.04M |
| 117 | KRYS | Krystal Biotech, Inc. | 8.12B | 1.20% | 367,722 | 389.13M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 8.12B | -1.60% | 232,541 | 2.58B |
| 119 | HALO | Halozyme Therapeutics, Inc. | 8.10B | -0.01% | 853,808 | 1.40B |
| 120 | MOH | Molina Healthcare, Inc. | 7.97B | 1.32% | 2,675,177 | 43.21B |
| 121 | ATR | AptarGroup, Inc. | 7.94B | -1.69% | 458,921 | 3.78B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.25B | 0.79% | 420,055 | 39.21M |
| 123 | GKOS | Glaukos Corporation | 7.12B | -0.38% | 459,706 | 507.44M |
| 124 | RGEN | Repligen Corporation | 7.02B | -6.25% | 1,016,373 | 738.26M |
| 125 | HQY | HealthEquity, Inc. | 7.00B | -1.68% | 659,382 | 1.31B |
| 126 | ACLX | Arcellx, Inc. | 6.75B | 0.02% | 1,044,553 | 22.29M |
| 127 | PTGX | Protagonist Therapeutics, Inc. | 6.74B | -0.32% | 345,923 | 46.02M |
| 128 | ERAS | Erasca, Inc. | 6.73B | -3.39% | 11,240,267 | - |
| 129 | GRFS | Grifols, S.A. | 6.73B | - | 3,701,041 | 8.83B |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.70B | -0.20% | 536,121 | - |
| 131 | HIMS | Hims & Hers Health, Inc. | 6.61B | -2.52% | 32,247,086 | 2.35B |
| 132 | BLTE | Belite Bio, Inc | 6.59B | 1.33% | 88,162 | - |
| 133 | SYRE | Spyre Therapeutics, Inc. | 6.30B | 2.43% | 1,070,643 | - |
| 134 | TFX | Teleflex Incorporated | 6.14B | 11.27% | 3,419,939 | 1.99B |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.05% | 3,483,245 | 15.00M |
| 136 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | -0.04% | 2,702,102 | - |
| 137 | BRKR | Bruker Corporation | 6.04B | -1.05% | 1,427,736 | 3.44B |
| 138 | IMVT | Immunovant, Inc. | 6.00B | 4.28% | 1,855,191 | - |
| 139 | CELC | Celcuity Inc. | 5.92B | -2.90% | 506,161 | - |
| 140 | CGON | CG Oncology, Inc. | 5.90B | -2.73% | 1,040,108 | 4.04M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.86B | 0.31% | 514,206 | 1.73B |
| 142 | COGT | Cogent Biosciences, Inc. | 5.86B | -0.93% | 1,424,254 | - |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.82B | 0.30% | 974,036 | 189.76M |
| 144 | CAI | Caris Life Sciences, Inc. | 5.79B | -1.58% | 1,301,913 | 812.03M |
| 145 | BLCO | Bausch + Lomb Corporation | 5.72B | 0.06% | 650,531 | 5.10B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 5.69B | 1.05% | 729,524 | 521.31M |
| 147 | TGTX | TG Therapeutics, Inc. | 5.66B | 5.60% | 2,297,669 | 616.29M |
| 148 | ALKS | Alkermes plc | 5.61B | 0.66% | 1,349,972 | 1.48B |
| 149 | AVTR | Avantor, Inc. | 5.60B | -2.93% | 9,152,083 | 6.55B |
| 150 | PACS | PACS Group, Inc. | 5.50B | -2.51% | 1,128,780 | 5.29B |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.44B | -1.60% | 970,895 | - |
| 152 | CRSP | CRISPR Therapeutics AG | 5.43B | 1.58% | 1,426,839 | 3.51M |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | 0.44% | 720,818 | 7.50M |
| 154 | LNTH | Lantheus Holdings, Inc. | 5.38B | 1.61% | 526,318 | 1.54B |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.23B | -0.12% | 2,180,583 | 1.00B |
| 156 | CHE | Chemed Corporation | 5.01B | -0.17% | 249,954 | 2.53B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.97B | 1.26% | 303,446 | 2.04M |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.95B | 3.26% | 727,097 | 761.41M |
| 159 | OSCR | Oscar Health, Inc. | 4.89B | 1.67% | 4,687,368 | 11.70B |
| 160 | WAY | Waystar Holding Corp. | 4.86B | -1.97% | 3,428,840 | 1.10B |
| 161 | LEGN | Legend Biotech Corporation | 4.80B | 2.82% | 3,256,835 | 1.03B |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 2,703,456 | 634.21M |
| 163 | RDNT | RadNet, Inc. | 4.53B | 0.56% | 817,259 | 2.04B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.52B | 0.09% | 113,896 | 268.09M |
| 165 | DOCS | Doximity, Inc. | 4.48B | 0.46% | 2,450,955 | 637.78M |
| 166 | SHC | Sotera Health Company | 4.46B | -2.13% | 1,972,498 | 1.16B |
| 167 | OPCH | Option Care Health, Inc. | 4.46B | 1.18% | 1,102,782 | 5.65B |
| 168 | NVST | Envista Holdings Corporation | 4.42B | -0.22% | 1,948,218 | 2.72B |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.29B | -2.55% | 2,631,576 | 3.95B |
| 170 | STVN | Stevanato Group S.p.A. | 4.25B | 1.37% | 483,944 | 1.39B |
| 171 | MMSI | Merit Medical Systems, Inc. | 4.16B | 2.73% | 543,920 | 1.52B |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.09B | 0.51% | 785,292 | 7.70M |
| 173 | AMRX | Amneal Pharmaceuticals, Inc. | 4.09B | -1.54% | 3,251,450 | 3.02B |
| 174 | BLLN | BillionToOne, Inc. | 3.99B | -2.43% | 222,010 | 305.11M |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.97B | 1.33% | 1,609,949 | - |
| 176 | TMDX | TransMedics Group, Inc. | 3.96B | 5.27% | 778,559 | 605.49M |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.94B | 2.58% | 217,544 | 747.14M |
| 178 | TNGX | Tango Therapeutics, Inc. | 3.89B | -2.99% | 3,157,131 | 62.38M |
| 179 | TWST | Twist Bioscience Corporation | 3.87B | 0.94% | 2,022,641 | 391.56M |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.79B | 2.02% | 1,180,129 | 1.07B |
| 181 | MMED | MiniMed Group, Inc. | 3.70B | -0.08% | 430,517 | 2.99B |
| 182 | TVTX | Travere Therapeutics, Inc. | 3.70B | 3.38% | 2,679,940 | 490.73M |
| 183 | NAMS | NewAmsterdam Pharma Company N.V. | 3.67B | -1.66% | 1,652,672 | 22.50M |
| 184 | LIVN | LivaNova PLC | 3.56B | 1.01% | 470,166 | 1.39B |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.48B | 0.98% | 151,837 | 803.79M |
| 186 | HNGE | Hinge Health, Inc. | 3.46B | 0.45% | 358,476 | 587.86M |
| 187 | ORKA | Oruka Therapeutics, Inc. | 3.45B | 0.99% | 1,141,885 | - |
| 188 | EWTX | Edgewise Therapeutics, Inc. | 3.45B | -0.86% | 658,036 | - |
| 189 | RCUS | Arcus Biosciences, Inc. | 3.34B | 8.56% | 4,112,689 | 247.00M |
| 190 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.31B | 1.39% | 703,429 | 677.56M |
| 191 | GPCR | Structure Therapeutics Inc. | 3.29B | -0.70% | 688,825 | - |
| 192 | ALMS | Alumis Inc. | 3.29B | 3.64% | 1,406,378 | 24.05M |
| 193 | LQDA | Liquidia Corporation | 3.27B | 2.23% | 804,973 | 158.32M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.25B | 2.39% | 2,148,963 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.21B | 0.60% | 1,424,877 | - |
| 196 | BKD | Brookdale Senior Living Inc. | 3.19B | 2.29% | 3,602,184 | 3.05B |
| 197 | ICUI | ICU Medical, Inc. | 3.18B | -0.66% | 176,807 | 2.23B |
| 198 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.17B | 1.17% | 703,252 | 588.99M |
| 199 | BEAM | Beam Therapeutics Inc. | 3.15B | 3.26% | 1,665,001 | 139.74M |
| 200 | RLAY | Relay Therapeutics, Inc. | 3.12B | -1.73% | 2,367,705 | 15.36M |
| 201 | WRBY | Warby Parker Inc. | 3.01B | -2.23% | 1,528,085 | 871.91M |
| 202 | KLRA | Kailera Therapeutics, Inc. | 3.01B | -3.65% | 891,939 | - |
| 203 | PRVA | Privia Health Group, Inc. | 3.00B | 1.10% | 477,374 | 2.12B |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 2.95B | 1.50% | 826,091 | 376.07M |
| 205 | TXG | 10x Genomics, Inc. | 2.92B | -0.61% | 2,873,462 | 642.82M |
| 206 | CON | Concentra Group Holdings Parent, Inc. | 2.91B | 1.62% | 444,379 | 2.16B |
| 207 | ITGR | Integer Holdings Corporation | 2.90B | -0.54% | 267,913 | 1.85B |
| 208 | SUPN | Supernus Pharmaceuticals, Inc. | 2.90B | 2.38% | 391,680 | 718.95M |
| 209 | VERA | Vera Therapeutics, Inc. | 2.89B | 0.52% | 651,271 | - |
| 210 | HAE | Haemonetics Corporation | 2.84B | 1.53% | 547,245 | 1.32B |
| 211 | HTFL | HeartFlow, Inc. | 2.82B | 3.39% | 1,356,216 | 176.03M |
| 212 | KOD | Kodiak Sciences Inc. | 2.79B | -2.06% | 434,595 | - |
| 213 | IDYA | IDEAYA Biosciences, Inc. | 2.78B | -0.50% | 983,821 | 218.71M |
| 214 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.11% | 1,653,471 | 190.41M |
| 215 | NHC | National HealthCare Corporation | 2.71B | 8.11% | 336,312 | 1.52B |
| 216 | PBH | Prestige Consumer Healthcare Inc. | 2.71B | -0.54% | 324,927 | 1.10B |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | -1.60% | 542,911 | 451.36M |
| 218 | LFST | LifeStance Health Group, Inc. | 2.69B | 1.77% | 1,292,202 | 1.42B |
| 219 | IMNM | Immunome, Inc. | 2.69B | -0.29% | 669,687 | 6.94M |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.68B | -0.12% | 787,270 | 1.55M |
| 221 | VCYT | Veracyte, Inc. | 2.68B | 0.60% | 538,418 | 517.15M |
| 222 | NKTR | Nektar Therapeutics | 2.67B | -5.05% | 3,715,750 | 55.23M |
| 223 | IRON | Disc Medicine, Inc. | 2.66B | 0.91% | 386,319 | - |
| 224 | ELVN | Enliven Therapeutics, Inc. | 2.66B | -3.16% | 744,159 | - |
| 225 | MANE | Veradermics, Incorporated | 2.63B | -4.14% | 433,844 | - |
| 226 | ACHC | Acadia Healthcare Company, Inc. | 2.58B | 2.08% | 2,522,368 | 3.31B |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.58B | 0.80% | 94,396 | 249.60M |
| 228 | ZLAB | Zai Lab Limited | 2.57B | -6.42% | 820,825 | 460.16M |
| 229 | ADMA | ADMA Biologics, Inc. | 2.54B | 1.58% | 5,094,811 | 510.17M |
| 230 | HCM | HUTCHMED (China) Limited | 2.44B | -2.08% | 15,674 | 548.51M |
| 231 | XRAY | DENTSPLY SIRONA Inc. | 2.43B | -1.14% | 2,074,684 | 3.68B |
| 232 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | 2.12% | 1,349,181 | 673.00M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 0.52% | 598,213 | - |
| 234 | OGN | Organon & Co. | 2.38B | 3.39% | 6,604,017 | 6.22B |
| 235 | AAPG | Ascentage Pharma Group International | 2.34B | -2.03% | 1,494 | 82.08M |
| 236 | DFTX | Definium Therapeutics, Inc. | 2.30B | -3.19% | 1,812,993 | - |
| 237 | GRDN | Guardian Pharmacy Services, Inc. | 2.30B | 0.67% | 248,396 | 1.45B |
| 238 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.26B | 5.01% | 3,725,914 | 874.84M |
| 239 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.19% | 2,988,826 | 158.18M |
| 240 | TYRA | Tyra Biosciences, Inc. | 2.22B | 1.80% | 948,163 | - |
| 241 | PAHC | Phibro Animal Health Corporation | 2.19B | -0.22% | 165,505 | 1.46B |
| 242 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | -0.07% | 1,040,237 | 276.98M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | 3.79% | 1,216,937 | 283.06M |
| 244 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -0.19% | 2,564,925 | 2.20B |
| 245 | GRAL | GRAIL, Inc. | 2.16B | 3.04% | 416,358 | 147.17M |
| 246 | STOK | Stoke Therapeutics, Inc. | 2.12B | 0.81% | 448,962 | 184.42M |
| 247 | BHC | Bausch Health Companies Inc. | 2.12B | -0.87% | 870,561 | 10.27B |
| 248 | ZYME | Zymeworks Inc. | 2.10B | 0.92% | 715,613 | 105.97M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.10B | 3.65% | 2,810,782 | 51.95M |
| 250 | TRVI | Trevi Therapeutics, Inc. | 2.07B | 1.23% | 1,339,944 | - |
| 251 | NEOG | Neogen Corporation | 2.07B | 1.06% | 2,137,109 | 870.56M |
| 252 | MESO | Mesoblast Limited | 2.05B | -2.72% | 230,195 | 65.38M |
| 253 | WGS | GeneDx Holdings Corp. | 2.05B | 2.54% | 497,430 | 427.54M |
| 254 | SEM | Select Medical Holdings Corporation | 2.04B | 0.06% | 1,167,085 | 5.45B |
| 255 | CAPR | Capricor Therapeutics, Inc. | 2.02B | -0.96% | 591,233 | 11.13M |
| 256 | ESTA | Establishment Labs Holdings Inc. | 1.97B | 4.73% | 494,185 | 211.08M |
| 257 | RXRX | Recursion Pharmaceuticals, Inc. | 1.97B | 4.78% | 10,281,978 | 74.68M |
| 258 | PHVS | Pharvaris N.V. | 1.96B | 3.05% | 239,282 | - |
| 259 | NTLA | Intellia Therapeutics, Inc. | 1.96B | 8.23% | 3,762,626 | 67.67M |
| 260 | SNDX | Syndax Pharmaceuticals, Inc. | 1.95B | -5.36% | 2,258,355 | 172.35M |
| 261 | SION | Sionna Therapeutics, Inc. | 1.94B | 3.37% | 363,351 | - |
| 262 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.94B | -0.40% | 657,228 | -665.00K |
| 263 | TSHA | Taysha Gene Therapies, Inc. | 1.93B | 8.04% | 3,073,321 | 9.77M |
| 264 | AXGN | Axogen, Inc. | 1.92B | 3.09% | 872,908 | 225.21M |
| 265 | GLPG | Galapagos NV | 1.92B | 0.76% | 82,792 | 1.31B |
| 266 | SGRY | Surgery Partners, Inc. | 1.89B | 1.03% | 925,151 | 3.31B |
| 267 | PVLA | Palvella Therapeutics, Inc. | 1.87B | -0.01% | 196,722 | - |
| 268 | MD | Pediatrix Medical Group, Inc. | 1.85B | -0.13% | 383,009 | 1.91B |
| 269 | HRMY | Harmony Biosciences Holdings, Inc. | 1.85B | -0.53% | 1,484,242 | 868.45M |
| 270 | ANIP | ANI Pharmaceuticals, Inc. | 1.82B | 0.25% | 218,163 | 883.37M |
| 271 | AORT | Artivion, Inc. | 1.80B | 1.29% | 279,950 | 441.33M |
| 272 | NUVB | Nuvation Bio Inc. | 1.78B | 0.20% | 2,517,135 | 62.90M |
| 273 | RAPP | Rapport Therapeutics, Inc. | 1.76B | -0.46% | 338,397 | - |
| 274 | VCEL | Vericel Corporation | 1.75B | 2.08% | 457,612 | 276.26M |
| 275 | INVA | Innoviva, Inc. | 1.74B | -0.47% | 448,663 | 411.33M |
| 276 | AHCO | AdaptHealth Corp. | 1.73B | 4.61% | 1,533,890 | 3.24B |
| 277 | VIR | Vir Biotechnology, Inc. | 1.72B | -1.48% | 2,405,465 | 68.56M |
| 278 | NRIX | Nurix Therapeutics, Inc. | 1.72B | 1.16% | 694,656 | 71.78M |
| 279 | ADUS | Addus HomeCare Corporation | 1.72B | 3.40% | 186,094 | 1.42B |
| 280 | ATAI | AtaiBeckley Inc. | 1.72B | -3.29% | 6,635,984 | 4.09M |
| 281 | AHG | Akso Health Group | 1.70B | 9.60% | 173,522 | 14.84M |
| 282 | INBX | Inhibrx Biosciences, Inc. | 1.68B | 36.88% | 2,735,062 | 1.30M |
| 283 | GLUE | Monte Rosa Therapeutics, Inc. | 1.68B | 0.43% | 1,103,123 | 123.67M |
| 284 | ASTH | Astrana Health, Inc. | 1.67B | 3.53% | 419,058 | 3.18B |
| 285 | OMCL | Omnicell, Inc. | 1.67B | -0.27% | 331,205 | 1.18B |
| 286 | PLSE | Pulse Biosciences, Inc. | 1.66B | 1.88% | 188,674 | 350.00K |
| 287 | GENB | Generate Biomedicines, Inc. | 1.66B | 2.84% | 329,484 | 31.89M |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.66B | 4.48% | 342,423 | 74.21M |
| 289 | OCS | Oculis Holding AG | 1.65B | 1.64% | 909,365 | 1.51M |
| 290 | PRGO | Perrigo Company plc | 1.63B | 0.77% | 2,098,493 | 4.25B |
| 291 | ATEC | Alphatec Holdings, Inc. | 1.61B | 1.34% | 2,113,202 | 764.16M |
| 292 | BHVN | Biohaven Ltd. | 1.61B | 4.81% | 1,579,342 | - |
| 293 | MBX | MBX Biosciences, Inc. | 1.60B | 1.02% | 341,752 | - |
| 294 | SNDA | Sonida Senior Living, Inc. | 1.59B | -0.87% | 425,942 | 336.39M |
| 295 | HCSG | Healthcare Services Group, Inc. | 1.58B | 18.29% | 2,594,397 | 1.85B |
| 296 | UFPT | UFP Technologies, Inc. | 1.57B | 2.55% | 173,390 | 602.80M |
| 297 | AGIO | Agios Pharmaceuticals, Inc. | 1.57B | 1.64% | 1,586,317 | 54.03M |
| 298 | DMRA | Damora Therapeutics, Inc. | 1.56B | -3.43% | 153,667 | - |
| 299 | INSP | Inspire Medical Systems, Inc. | 1.56B | 4.17% | 492,527 | 911.98M |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.55B | 2.25% | 603,440 | - |
| 301 | ANAB | AnaptysBio, Inc. | 1.54B | 3.34% | 605,317 | 234.60M |
| 302 | NBTX | Nanobiotix S.A. | 1.54B | 4.53% | 41,310 | 38.27M |
| 303 | IMCR | Immunocore Holdings plc | 1.52B | 1.56% | 341,191 | 400.02M |
| 304 | IMTX | Immatics N.V. | 1.51B | 0.72% | 180,599 | 56.67M |
| 305 | NVCR | NovoCure Limited | 1.51B | 6.46% | 1,371,845 | 655.35M |
| 306 | CRVS | Corvus Pharmaceuticals, Inc. | 1.50B | 4.14% | 3,376,360 | - |
| 307 | VRDN | Viridian Therapeutics, Inc. | 1.48B | 0.35% | 1,400,249 | 70.85M |
| 308 | ARDX | Ardelyx, Inc. | 1.48B | 1.01% | 2,963,214 | 407.32M |
| 309 | HROW | Harrow, Inc. | 1.46B | -0.79% | 556,390 | 272.30M |
| 310 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | -4.59% | 22,203,968 | 263.50M |
| 311 | TNDM | Tandem Diabetes Care, Inc. | 1.42B | 3.74% | 1,300,955 | 1.01B |
| 312 | WVE | Wave Life Sciences Ltd. | 1.42B | 0.54% | 3,550,837 | 42.73M |
| 313 | PRCT | PROCEPT BioRobotics Corporation | 1.42B | 1.41% | 1,160,593 | 308.05M |
| 314 | OLMA | Olema Pharmaceuticals, Inc. | 1.42B | -2.35% | 953,455 | - |
| 315 | MPLT | MapLight Therapeutics, Inc. | 1.41B | 16.33% | 610,023 | - |
| 316 | ARDT | Ardent Health, Inc. | 1.41B | 1.13% | 204,685 | 6.32B |
| 317 | PGNY | Progyny, Inc. | 1.41B | -0.17% | 1,475,100 | 1.29B |
| 318 | BFLY | Butterfly Network, Inc. | 1.41B | 1.47% | 4,423,626 | 97.61M |
| 319 | AVAH | Aveanna Healthcare Holdings Inc. | 1.41B | 0.94% | 1,022,850 | 2.43B |
| 320 | PGEN | Precigen, Inc. | 1.40B | -0.50% | 1,640,417 | 9.68M |
| 321 | ATRC | AtriCure, Inc. | 1.40B | 0.95% | 988,619 | 534.53M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.39B | 2.63% | 296,090 | 83.72M |
| 323 | NVAX | Novavax, Inc. | 1.38B | -0.47% | 3,523,198 | 1.12B |
| 324 | ENOV | Enovis Corporation | 1.37B | 0.13% | 906,028 | 2.25B |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.37B | -0.27% | 247,039 | - |
| 326 | MAZE | Maze Therapeutics, Inc. | 1.32B | 3.15% | 2,220,576 | 2.50M |
| 327 | CLOV | Clover Health Investments, Corp. | 1.31B | 4.60% | 7,763,608 | 1.92B |
| 328 | SVRA | Savara Inc. | 1.30B | -2.65% | 1,393,241 | - |
| 329 | URGN | UroGen Pharma Ltd. | 1.27B | 4.12% | 1,779,080 | 109.79M |
| 330 | JBIO | Jade Biosciences, Inc. | 1.25B | 10.30% | 1,261,503 | - |
| 331 | NNNN | Anbio Biotechnology | 1.25B | 4.71% | 34,029 | 8.65M |
| 332 | ABCL | AbCellera Biologics Inc. | 1.24B | 2.26% | 5,347,643 | 75.13M |
| 333 | MLTX | MoonLake Immunotherapeutics | 1.24B | - | 1,213,288 | - |
| 334 | STAA | STAAR Surgical Company | 1.23B | -0.48% | 740,903 | 239.44M |
| 335 | AZTA | Azenta, Inc. | 1.22B | 0.68% | 780,240 | 595.03M |
| 336 | AKTS | Aktis Oncology, Inc. | 1.22B | 7.32% | 302,813 | 6.50M |
| 337 | ZBIO | Zenas BioPharma, Inc. | 1.19B | -1.81% | 507,482 | 10.00M |
| 338 | PHAR | Pharming Group N.V. | 1.19B | -0.29% | 3,544 | 376.13M |
| 339 | EYPT | EyePoint, Inc. | 1.19B | 0.92% | 989,008 | 31.37M |
| 340 | EVO | Evotec SE | 1.18B | 2.17% | 61,693 | 925.65M |
| 341 | CMPS | COMPASS Pathways plc | 1.18B | -5.41% | 7,057,488 | - |
| 342 | GHRS | GH Research PLC | 1.18B | -8.23% | 533,594 | - |
| 343 | DBVT | DBV Technologies S.A. | 1.16B | -1.05% | 292,236 | 5.64M |
| 344 | SEPN | Septerna, Inc. | 1.16B | 0.23% | 255,587 | 45.95M |
| 345 | CNMD | CONMED Corporation | 1.16B | 0.37% | 296,611 | 1.37B |
| 346 | IRMD | IRADIMED CORPORATION | 1.15B | 1.08% | 63,609 | 83.81M |
| 347 | AVNS | Avanos Medical, Inc. | 1.15B | 0.04% | 1,346,515 | 701.20M |
| 348 | USPH | U.S. Physical Therapy, Inc. | 1.14B | -0.01% | 137,610 | 773.34M |
| 349 | QURE | uniQure N.V. | 1.12B | 1.89% | 594,026 | 16.10M |
| 350 | IVA | Inventiva S.A. | 1.11B | -2.78% | 142,731 | 7.94M |
| 351 | BLFS | BioLife Solutions, Inc. | 1.10B | 1.92% | 394,064 | 96.21M |
| 352 | ALVO | Alvotech | 1.10B | -0.28% | 338,578 | 588.90M |
| 353 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | 1.32% | 1,741,665 | - |
| 354 | COLL | Collegium Pharmaceutical, Inc. | 1.07B | -0.63% | 296,066 | 780.57M |
| 355 | TDOC | Teladoc Health, Inc. | 1.07B | -1.33% | 5,791,333 | 2.53B |
| 356 | CRON | Cronos Group Inc. | 1.07B | 2.56% | 15,383,162 | 146.59M |
| 357 | NEO | NeoGenomics, Inc. | 1.06B | 2.76% | 1,913,645 | 727.33M |
| 358 | CDNA | CareDx, Inc. | 1.06B | -0.48% | 477,425 | 379.81M |
| 359 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 2.55% | 1,428,126 | 291.85M |
| 360 | INNV | InnovAge Holding Corp. | 1.04B | 0.79% | 179,495 | 915.37M |
| 361 | PNTG | The Pennant Group, Inc. | 1.03B | 1.63% | 263,021 | 947.71M |
| 362 | ANNX | Annexon, Inc. | 1.02B | 0.97% | 1,848,122 | - |
| 363 | SANA | Sana Biotechnology, Inc. | 1.01B | -0.27% | 2,321,663 | - |
| 364 | PCRX | Pacira BioSciences, Inc. | 1.01B | 0.97% | 360,573 | 726.41M |
| 365 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | 0.67% | 988,938 | 73.62M |
| 366 | CTMX | CytomX Therapeutics, Inc. | 996.58M | -3.15% | 3,003,935 | 76.20M |
| 367 | GERN | Geron Corporation | 993.40M | 3.33% | 16,683,710 | 183.88M |
| 368 | FTRE | Fortrea Holdings Inc. | 981.75M | 1.74% | 900,248 | 2.72B |
| 369 | CERT | Certara, Inc. | 978.21M | 2.90% | 3,188,411 | 418.84M |
| 370 | EVMN | Evommune, Inc. | 976.82M | -3.38% | 126,633 | 13.00M |
| 371 | OMER | Omeros Corporation | 962.59M | 0.83% | 890,414 | - |
| 372 | CMPX | Compass Therapeutics, Inc. | 958.07M | 1.53% | 1,848,926 | 850.00K |
| 373 | ANRO | Alto Neuroscience, Inc. | 952.03M | 6.14% | 335,643 | - |
| 374 | MRVI | Maravai LifeSciences Holdings, Inc. | 948.58M | 0.27% | 2,462,404 | 185.74M |
| 375 | XNCR | Xencor, Inc. | 942.40M | 1.90% | 630,860 | 125.58M |
| 376 | JANX | Janux Therapeutics, Inc. | 936.20M | -0.45% | 612,978 | 10.00M |
| 377 | AMPH | Amphastar Pharmaceuticals, Inc. | 934.79M | -1.04% | 410,776 | 719.89M |
| 378 | OPK | OPKO Health, Inc. | 933.65M | 0.82% | 1,637,888 | 606.88M |
| 379 | PHAT | Phathom Pharmaceuticals, Inc. | 931.72M | -8.93% | 2,043,455 | 175.11M |
| 380 | MGTX | MeiraGTx Holdings plc | 928.35M | -1.38% | 1,002,599 | 81.39M |
| 381 | SSII | SS Innovations International, Inc. | 919.72M | - | 30,405 | 42.48M |
| 382 | TLRY | Tilray Brands, Inc. | 914.71M | 14.22% | 29,406,344 | 858.28M |
| 383 | INMD | InMode Ltd. | 913.00M | -0.69% | 478,192 | 370.50M |
| 384 | SDGR | Schrödinger, Inc. | 911.74M | -4.11% | 1,869,900 | 255.87M |
| 385 | LBRX | LB Pharmaceuticals Inc | 911.29M | - | 254,010 | - |
| 386 | LMRI | Lumexa Imaging Holdings, Inc. | 896.71M | 0.11% | 530,571 | 1.02B |
| 387 | CBIO | Crescent Biopharma, Inc. | 896.11M | 9.81% | 583,248 | 10.84M |
| 388 | DRUG | Bright Minds Biosciences Inc. | 875.40M | 3.12% | 153,487 | - |
| 389 | ABUS | Arbutus Biopharma Corporation | 872.44M | - | 938,948 | 14.08M |
| 390 | TALK | Talkspace, Inc. | 867.12M | - | 591,424 | 228.87M |
| 391 | OMDA | Omada Health, Inc. | 860.90M | 2.24% | 449,761 | 260.21M |
| 392 | SLS | SELLAS Life Sciences Group, Inc. | 858.40M | -4.97% | 5,293,511 | - |
| 393 | TBPH | Theravance Biopharma, Inc. | 853.24M | -0.30% | 445,035 | 107.46M |
| 394 | MNKD | MannKind Corporation | 846.10M | 1.48% | 3,928,163 | 348.97M |
| 395 | KURA | Kura Oncology, Inc. | 845.91M | 0.63% | 982,763 | 67.48M |
| 396 | IART | Integra LifeSciences Holdings Corporation | 837.82M | 2.19% | 802,636 | 1.64B |
| 397 | CGEM | Cullinan Therapeutics, Inc. | 837.68M | -2.67% | 481,373 | - |
| 398 | SPRY | ARS Pharmaceuticals, Inc. | 834.10M | 7.14% | 3,892,067 | 84.28M |
| 399 | VOR | Vor Biopharma Inc. | 830.12M | 0.99% | 1,047,651 | - |
| 400 | SLDB | Solid Biosciences Inc. | 826.52M | 2.94% | 733,065 | - |
| 401 | DSGN | Design Therapeutics, Inc. | 824.56M | 0.60% | 493,739 | - |
| 402 | ALLO | Allogene Therapeutics, Inc. | 822.11M | 3.02% | 9,426,378 | 22.00K |
| 403 | SGP | SpyGlass Pharma, Inc. | 818.62M | 0.84% | 54,813 | - |
| 404 | BIOA | BioAge Labs, Inc. | 814.81M | -6.37% | 393,568 | 9.00M |
| 405 | BVS | Bioventus Inc. | 812.42M | 1.35% | 440,828 | 568.09M |
| 406 | GDRX | GoodRx Holdings, Inc. | 811.90M | 2.60% | 1,366,137 | 796.85M |
| 407 | QDEL | QuidelOrtho Corporation | 810.17M | -1.16% | 2,198,024 | 2.73B |
| 408 | AMN | AMN Healthcare Services, Inc. | 808.30M | 0.38% | 560,321 | 2.73B |
| 409 | CBLL | CeriBell, Inc. | 802.89M | 1.86% | 290,346 | 89.06M |
| 410 | LXRX | Lexicon Pharmaceuticals, Inc. | 771.10M | -0.55% | 1,401,918 | 49.80M |
| 411 | CSTL | Castle Biosciences, Inc. | 760.43M | 2.12% | 226,888 | 344.23M |
| 412 | NUTX | Nutex Health Inc. | 755.30M | 2.08% | 122,314 | 875.26M |
| 413 | RLMD | Relmada Therapeutics, Inc. | 740.51M | -1.12% | 1,203,821 | - |
| 414 | FBRX | Forte Biosciences, Inc. | 730.19M | -9.17% | 227,100 | - |
| 415 | DRTS | Alpha Tau Medical Ltd. | 711.12M | 2.28% | 142,352 | - |
| 416 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 709.89M | -6.24% | 796,529 | - |
| 417 | GYRE | Gyre Therapeutics, Inc. | 705.86M | -1.78% | 34,303 | 116.59M |
| 418 | PRME | Prime Medicine, Inc. | 701.24M | 3.94% | 1,772,368 | 4.63M |
| 419 | TENX | Tenax Therapeutics, Inc. | 700.18M | 1.75% | 456,530 | - |
| 420 | EHAB | Enhabit, Inc. | 696.43M | 0.07% | 457,135 | 1.06B |
| 421 | IRWD | Ironwood Pharmaceuticals, Inc. | 681.58M | 2.70% | 1,199,884 | 296.15M |
| 422 | ARVN | Arvinas, Inc. | 679.91M | 0.09% | 648,439 | 262.60M |
| 423 | PSNL | Personalis, Inc. | 660.52M | 1.12% | 1,333,567 | 69.65M |
| 424 | TRAX | First Tracks Biotherapeutics, Inc. | 655.71M | 11.00% | 843,404 | - |
| 425 | BWAY | BrainsWay Ltd. | 648.57M | 3.39% | 71,649 | 52.23M |
| 426 | ANL | Adlai Nortye Ltd. | 645.20M | 1.07% | 550,597 | 5.00M |
| 427 | ETON | Eton Pharmaceuticals, Inc. | 644.19M | 0.30% | 226,894 | 79.95M |
| 428 | PROK | ProKidney Corp. | 631.10M | - | 571,293 | 893.00K |
| 429 | HSTM | HealthStream, Inc. | 629.77M | 0.51% | 135,194 | 304.06M |
| 430 | EIKN | Eikon Therapeutics, Inc. | 628.01M | -1.19% | 132,800 | - |
| 431 | KYTX | Kyverna Therapeutics, Inc. | 619.22M | 5.36% | 6,106,870 | - |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 615.88M | 0.96% | 803,408 | 106.47M |
| 433 | SIBN | SI-BONE, Inc. | 612.57M | 0.36% | 428,195 | 200.93M |
| 434 | ACRS | Aclaris Therapeutics, Inc. | 610.19M | 5.28% | 2,272,504 | 7.83M |
| 435 | CTKB | Cytek Biosciences, Inc. | 597.76M | 0.43% | 481,657 | 201.49M |
| 436 | STRO | Sutro Biopharma, Inc. | 588.63M | 3.44% | 217,584 | 102.48M |
| 437 | CRMD | CorMedix Inc. | 587.43M | 1.49% | 882,385 | 311.71M |
| 438 | STTK | Shattuck Labs, Inc. | 585.76M | -0.13% | 410,203 | 1.00M |
| 439 | LYEL | Lyell Immunopharma, Inc. | 578.08M | 3.64% | 71,996 | 36.00K |
| 440 | PRTA | Prothena Corporation plc | 577.09M | 0.47% | 350,784 | 9.68M |
| 441 | ENGN | enGene Therapeutics Inc. | 572.09M | 0.35% | 340,973 | - |
| 442 | NPCE | NeuroPace, Inc. | 571.66M | 3.73% | 253,506 | 99.99M |
| 443 | TCMD | Tactile Systems Technology, Inc. | 567.85M | 0.65% | 266,111 | 329.52M |
| 444 | OCGN | Ocugen, Inc. | 567.67M | -5.08% | 12,455,440 | 4.41M |
| 445 | PHR | Phreesia, Inc. | 566.31M | -0.43% | 1,254,521 | 480.59M |
| 446 | ABSI | Absci Corporation | 563.12M | -5.64% | 5,640,867 | 2.80M |
| 447 | RIGL | Rigel Pharmaceuticals, Inc. | 562.88M | -5.64% | 522,348 | 294.28M |
| 448 | AVR | Anteris Technologies Global Corp. | 550.27M | -0.18% | 551,975 | 1.91M |
| 449 | EMBC | Embecta Corp. | 545.41M | 0.88% | 713,650 | 1.08B |
| 450 | BBNX | Beta Bionics, Inc. | 543.65M | -0.57% | 2,313,914 | 110.24M |
| 451 | ZURA | Zura Bio Limited | 539.87M | 7.56% | 737,263 | - |
| 452 | IMMX | Immix Biopharma, Inc. | 539.66M | 5.17% | 596,581 | - |
| 453 | CADL | Candel Therapeutics, Inc. | 537.63M | 4.86% | 2,548,739 | - |
| 454 | CATX | Perspective Therapeutics, Inc. | 537.02M | 1.51% | 2,093,193 | 884.00K |
| 455 | TECX | Tectonic Therapeutic, Inc. | 535.13M | 3.11% | 242,707 | - |
| 456 | VSTM | Verastem, Inc. | 533.21M | 0.33% | 1,600,514 | 30.91M |
| 457 | CGC | Canopy Growth Corporation | 526.86M | 21.05% | 60,337,735 | 203.04M |
| 458 | UPB | Upstream Bio, Inc. | 524.61M | 4.10% | 624,770 | 2.85M |
| 459 | ADCT | ADC Therapeutics SA | 520.21M | -0.49% | 651,454 | 81.36M |
| 460 | PACB | Pacific Biosciences of California, Inc. | 516.42M | -1.16% | 4,714,384 | 160.01M |
| 461 | FULC | Fulcrum Therapeutics, Inc. | 516.15M | 2.92% | 816,781 | 80.00M |
| 462 | AGMB | AgomAb Therapeutics NV | 514.17M | -3.65% | 64,761 | - |
| 463 | ARMP | Armata Pharmaceuticals, Inc. | 509.56M | -6.01% | 63,425 | 4.90M |
| 464 | VREX | Varex Imaging Corporation | 508.90M | 1.17% | 171,205 | 854.40M |
| 465 | ESPR | Esperion Therapeutics, Inc. | 507.09M | 2.60% | 9,830,103 | 403.14M |
| 466 | AQST | Aquestive Therapeutics, Inc. | 506.49M | -4.38% | 2,153,263 | 44.55M |
| 467 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 468 | VTVT | vTv Therapeutics Inc. | 501.97M | 5.06% | 126,139 | 17.00K |
| 469 | FDMT | 4D Molecular Therapeutics, Inc. | 500.30M | 0.41% | 685,415 | 85.21M |
| 470 | MDXG | MiMedx Group, Inc. | 491.76M | 3.44% | 1,428,517 | 418.63M |
| 471 | DNA | Ginkgo Bioworks Holdings, Inc. | 491.27M | 2.80% | 846,244 | 170.16M |
| 472 | OFIX | Orthofix Medical Inc. | 487.35M | 0.33% | 262,461 | 822.31M |
| 473 | VALN | Valneva SE | 485.03M | -11.47% | 463,795 | 205.07M |
| 474 | CTNM | Contineum Therapeutics, Inc. | 483.88M | -1.44% | 237,139 | - |
| 475 | KMDA | Kamada Ltd. | 482.84M | 2.96% | 43,255 | 180.46M |
| 476 | RGNX | REGENXBIO Inc. | 482.10M | 2.52% | 401,470 | 170.44M |
| 477 | AURA | Aura Biosciences, Inc. | 480.49M | 0.67% | 261,739 | - |
| 478 | MYGN | Myriad Genetics, Inc. | 479.77M | 1.80% | 717,126 | 824.50M |
| 479 | LRMR | Larimar Therapeutics, Inc. | 473.71M | -0.22% | 1,000,628 | - |
| 480 | AGL | agilon health, inc. | 469.96M | 15.69% | 400,029 | 5.93B |
| 481 | FLGT | Fulgent Genetics, Inc. | 469.88M | 2.20% | 447,687 | 322.67M |
| 482 | TRDA | Entrada Therapeutics, Inc. | 469.80M | -0.15% | 169,400 | 25.42M |
| 483 | XOMA | XOMA Royalty Corporation | 469.12M | -0.53% | 150,528 | 52.15M |
| 484 | LXEO | Lexeo Therapeutics, Inc. | 468.97M | 0.64% | 1,062,672 | - |
| 485 | ANGO | AngioDynamics, Inc. | 463.92M | 3.82% | 414,351 | 313.73M |
| 486 | IVVD | Invivyd, Inc. | 452.49M | 0.63% | 1,249,017 | 53.43M |
| 487 | ALT | Altimmune, Inc. | 451.46M | 1.76% | 2,948,086 | 41.00K |
| 488 | ASMB | Assembly Biosciences, Inc. | 448.91M | 5.01% | 80,933 | 72.30M |
| 489 | AVIR | Atea Pharmaceuticals, Inc. | 446.96M | 1.63% | 170,312 | - |
| 490 | CLYM | Climb Bio, Inc. | 444.25M | -0.75% | 1,532,335 | - |
| 491 | BNTC | Benitec Biopharma Inc. | 443.94M | -1.67% | 107,293 | - |
| 492 | IPSC | Century Therapeutics, Inc. | 440.24M | 6.30% | 1,016,384 | 109.16M |
| 493 | EPRX | Eupraxia Pharmaceuticals Inc. | 435.80M | 0.57% | 126,657 | - |
| 494 | PRLD | Prelude Therapeutics Incorporated | 433.38M | -6.71% | 321,031 | 12.14M |
| 495 | SRTA | Strata Critical Medical, Inc. | 432.23M | 4.38% | 1,235,600 | 197.14M |
| 496 | EBS | Emergent BioSolutions Inc. | 428.13M | 3.62% | 403,995 | 742.90M |
| 497 | WEAV | Weave Communications, Inc. | 426.28M | - | 1,159,406 | 239.02M |
| 498 | NGNE | Neurogene Inc. | 425.84M | 2.91% | 109,204 | 925.00K |
| 499 | AUTL | Autolus Therapeutics plc | 425.83M | 3.23% | 1,037,323 | 75.39M |
| 500 | PRTC | PureTech Health plc | 424.18M | -1.11% | 4,095 | 6.39M |